Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03937141
Title Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aduro Biotech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35294 United States Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
Yale University Cancer Center New Haven Connecticut 06520 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Emory University Hospital Atlanta Georgia 30308 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
University of Kansas Westwood Kansas 66205 United States Details
James Graham Brown Cancer Center Louisville Kentucky 40202 United States Details
University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Regions Cancer Care Center Saint Paul Minnesota 55101 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
University Pittsburgh Medical Center Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
MUSC Hollings Cancer Center Charleston South Carolina 29425 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
Baylor University Medical Center Dallas Texas 75246 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field